T0	Participants 104 134	chemotherapy in breast cancer.
T1	Participants 385 407	breast cancer subtype.
T2	Participants 515 608	Patients with invasive breast cancer were enrolled in the INTENS study between 2006 and 2009.
T3	Participants 609 735	We included 182 patients, of whom data were available for post-NAC MRI (n=155), US (n=123), and histopathological tumour size.